Skip to content Skip to sidebar Skip to footer

Healthcare Stocks

Chemist Warehouse is now ASX listed! Here are 5 critical things all investors need to know!

Chemist Warehouse is now ASX listed - 14 months since the plan to list was first unveiled. Australia's largest pharmacy chain had long been mulled as an IPO candidate. But - with IPO conditions less than ideal - it chose to list via a reverse takeover of Sigma Healthcare (ASX:SIG). The irony is that despite…

ByNick SundichFebruary 14, 2025

Alterity Therapeutics (ASX:ATH) more than doubled after its Phase 2 results, but its still only $80m

Alterity Therapeutics (ASX:ATH) hit the jackpot last week. Any clinical-stage biotech achieving a positive Phase 2 outcome is good news, because it depicts that the company's drug is not just safe, but that it works too. But while some companies (like Paradigm (ASX:PAR)) are going after markets with existing drugs that need replacement, Alterity is…

ByNick SundichFebruary 3, 2025

Paradigm Biopharmaceuticals’ flagship drug Zilosul will be in Phase 3 in 2025

Paradigm Biopharmaceuticals (ASX:PAR) has been listed for nearly a decade with the goal of bringing its flagship drug pentosan polysulfate sodum (PPS) (now known as Zilosul) to market. It is still a couple of years away, but is about to make a major step towards this goal in starting a Phase 3 trial. And we…

ByNick SundichJanuary 23, 2025

Here are 3 ASX stocks fighting diabetes and the opportunity ahead of them

There aren't many ASX stocks fighting diabetes, but the few that are have a big market opportunity ahead of them. And they are not just about fighting the condition directly but other ailments that can result from having diabetes. It is estimated that 537m people have diabetes globally and 3 out of 4 of them live in…

ByNick SundichJanuary 21, 2025

The Top ASX Health Stocks for 2025: Here Are Our 5 Picks!

Here Are Our 5 Top ASX Health Stocks for 2025! Avita Medical (ASX:AVH) OK, first thing's first. We know this ASX health stock fell 14% on January 8 after it announced a revenue downgrade for Q4. But the past is the past. The company told investors to expect $100-106m revenue in CY25, 55-65% above…

ByNick SundichJanuary 10, 2025

Here are our 6 Best ASX Stocks for 2025 and why you should give them a look!

Here are our 6 Best ASX Stocks for 2025! Opthea (ASX:OPT) Its been a long wait, but 2025 will finally be the year Opthea (ASX:OPT) investors receive Phase 3 results. Opthea is an optometry biotech developing Sozinibercept - a drug fighting wet AMD. Wet AMD is the leading cause of blindness, impacting 3.5m people annually…

ByNick SundichDecember 27, 2024

5 Promising Stocks Fighting Alzheimers to Watch Now

Let's take a look at the most promising stocks fighting Alzheimers disease. Alzheimer’s disease is one of the most daunting medical challenges of our time, with millions affected worldwide and no definitive cure in sight. There are few drugs that can fight Alzheimer’s, and they only fight symptoms and may not work until a later…

ByUjjwal MaheshwariDecember 19, 2024

Here are 6 of the best performing ASX shares in 2024! Will they maintain the momentum in 2025?

Here are 6 of the best performing ASX shares in 2024! Mesoblast (ASX:MSB) - up 527% How about this for a turnaround? This stock would've found itself in the list of worst performing shares for at least 2 of the last 3 calendar years (2021 and 2023) when it shed over 66% both years. It…

ByNick SundichDecember 19, 2024

How Could Ramsay Health Care Be Impacted by the Growing Costs of Private Healthcare in Australia?

In recent years, the cost of private healthcare in Australia has risen significantly, driven by an aging population, advancements in medical technology, and inflationary pressures on wages and materials. Ramsay Health Care (Ramsay), the Aussie healthcare giant, is feeling the heat. Despite a robust financial year for the company, with revenues soaring 9.4% to a…

ByUjjwal MaheshwariDecember 17, 2024

Here’s why Proteomics (ASX:PIQ) shareholders should brace themselves for a big 2025!

Proteomics (ASX:PIQ) is one of the healthcare stocks to watch in CY25, because it has not one, not two, but three diagnostic tests to be commercialised in Australia, the USA and Europe. It has been a long wait to get to this point, but investors can be confident that there is upside to be realised if…

ByNick SundichDecember 12, 2024

the Kick-ass Multipurpose WordPress Theme

Healthcare Stocks

Chemist Warehouse is now ASX listed! Here are 5 critical things all investors need to know!

Alterity Therapeutics (ASX:ATH) more than doubled after its Phase 2 results, but its still only $80m

Paradigm Biopharmaceuticals’ flagship drug Zilosul will be in Phase 3 in 2025

Here are 3 ASX stocks fighting diabetes and the opportunity ahead of them

The Top ASX Health Stocks for 2025: Here Are Our 5 Picks!

Here are our 6 Best ASX Stocks for 2025 and why you should give them a look!

5 Promising Stocks Fighting Alzheimers to Watch Now

Here are 6 of the best performing ASX shares in 2024! Will they maintain the momentum in 2025?

How Could Ramsay Health Care Be Impacted by the Growing Costs of Private Healthcare in Australia?

Here’s why Proteomics (ASX:PIQ) shareholders should brace themselves for a big 2025!

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Healthcare Stocks

Add Your Heading Text Here